Drug Type Trispecific T-cell engager (TriTE) |
Synonyms THL-1 |
Target |
Action modulators, stimulants |
Mechanism CD28 modulators(T-cell-specific surface glycoprotein CD28 modulators), CD3 stimulants(T cell surface glycoprotein CD3 stimulants), Cells modulators |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Solid tumor | Discovery | China | - |